PRMA Consulting - Building a healthier Asia

C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Roche Launches COVID-19 PCR Test for Omicron Sub-Variant

Friday, January 27, 2023

Roche and its subsidiary TIB Molbiol developed a COVID PCR test for researchers to detect and differentiate the latest variant of concern XBB The XBB variant is prevalent in the United States and is quickly spreading to other countries Being able to...

Evotec Enters into Agreement with Janssen

Friday, January 27, 2023

Evotec SE announced a strategic collaboration and licence agreement with Janssen Biotech Inc Janssen one of the Janssen Pharmaceutical Companies of Johnson Johnson The collaboration mainly focuses on the development of firstinclass targeted immuneba...

CytomX Therapeutics Announces Probody® T-Cell Engaging Bispecific (TCB) Achievement in Collaboration with Astellas

Friday, January 27, 2023

CytomX Therapeutics Inc today announced that it has achieved a clinical candidate milestone under its TCB agreement with Astellas The clinical candidate is the first Probody TCB molecule to progress in the collaboration and will trigger a million do...

US FDA Accepts Supplemental New Drug Application for Jardiance®

Wednesday, January 25, 2023

Boehringer Ingelheim and Eli Lilly and Company announced that the US Food and Drug Administration FDA has accepted a supplemental New Drug Application sNDA for Jardiance empagliflozin tablets which is being investigated as a potential treatment to re...

Thermo Fisher Scientific Partners with AstraZeneca to Develop Test for Tagrisso

Wednesday, January 25, 2023

Thermo Fisher Scientific announced to partner with AstraZeneca to develop a solid tissue and bloodbased companion diagnostic CDx test for Tagrisso osimertinib The CDx helps in identify patients with nonsmall cell lung cancer NSCLC eligible for treatm...

Lupin Digital Health Launches LYFE, Digital Therapeutic Solution

Wednesday, January 25, 2023

Lupin Digital Health a whollyowned subsidiary of global pharma major Lupin announced the launch of its digital therapeutics solution LYFE LYFE helps patients in improving their heart health through doctorconnected online and offline modules LYFEs sim...

Medicines Announces FDA Acceptance of Supplemental New Drug Application for AYVAKIT® (avapritinib)

Tuesday, January 24, 2023

Blueprint Medicines Corporation announced that the US Food and Drug Administration FDA has accepted the companys supplemental new drug application for AYVAKIT avapritinib for the treatment of adults with indolent systemic mastocytosis SM The FDA gran...

Takeda to Acquire Exclusive Worldwide (ex-China) License of HUTCHMED’s Fruquintinib q

Tuesday, January 24, 2023

Takeda announced that it has entered into an exclusive licensing agreement with HUTCHMED China Limited and its subsidiary HUTCHMED Limited for the further development and commercialisation of fruquintinib outside of mainland China Hong Kong and Macau...

TScan Therapeutics Announces FDA Clearance of Three Investigational New Drug Applications

Tuesday, January 24, 2023

TScan Therapeutics Inc announced that the US Food and Drug Administration FDA has cleared its investigational new drug IND applications for TPlex TSCA and TSCC TPlex serves as the primary IND for TScans solid tumour programme enabling customised comb...

US FDA accepts supplemental New Drug Application for Jardiance® for adults with chronic kidney disease

Saturday, January 21, 2023

The US Food and Drug Administration FDA has accepted a supplemental New Drug Application sNDA for Jardiance empagliflozin tablets which is being investigated as a potential treatment to reduce the risk of kidney disease progression and cardiovascular...

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEA SGS - ADVANCED ANALYTICS INTERPHEX 2023 Thermo Fisher Scientific - Gibco solutions ACG - Barrier Packaging